Enovis Corporation (ENOV) Insider Trading

Last 12 months

Insiders bought $736k on the open market and sold nothing.

Net open-market

+$736k

12 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

3 / 0

executives and directors

Last open-market buy

Sep 2026

Sep 4, 2026

Get an email when ENOV's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 4	Oliver Engert Chief Administrative Officer	Bought	2,660	$18.80	$50k	4.3%	Form 4
Sep 4	Damien McDonald Chief Executive Officer	Bought	13,035	$19.15	$250k	5.6%	Form 4
Sep 2 – 3	Oliver Engert Chief Administrative Officer	Bought 2 parts	7,598	$19.74 average	$150k	14%	Form 4
Jun 15	Oliver Engert Chief Administrative Officer	Bought	1,000	$20.92	$21k	1.9%	Form 4
Jun 10	Oliver Engert Chief Administrative Officer	Bought	1,000	$23.00	$23k	2.0%	Form 4
Jun 1	Oliver Engert Chief Administrative Officer	Bought	1,000	$22.22	$22k	2.1%	Form 4
Mar 13	Oliver Engert Chief Administrative Officer	Bought	1,000	$23.74	$24k	2.1%	Form 4
Mar 10	Oliver Engert Chief Administrative Officer	Bought	1,000	$23.93	$24k	2.1%	Form 4
Mar 6 – 9	Oliver Engert Chief Administrative Officer	Bought 3 parts	1,750	$23.83 average	$42k	3.9%	Form 4
Mar 3 – 4	Oliver Engert Chief Administrative Officer	Bought 2 parts	1,250	$24.84 average	$31k	2.9%	Form 4
Feb 27	Oliver Engert Chief Administrative Officer	Bought	1,000	$25.50	$26k	2.3%	Form 4
Dec 9, 2025	Daniel A Pryor Other	SoldNo plan 4 parts	1,665	$27.21 average	$45k	1.0%	Form 4
Nov 25, 2025	John Kleckner Principal Accounting Officer	Bought	2,468	$30.32	$75k	25%	Form 4
Sep 11, 2025	Damien McDonald Chief Executive Officer	Bought	6,457	$30.97	$200k	6.7%	Form 4
Aug 22, 2025	Bradley J Tandy SVP and Chief Legal Officer	Bought	3,200	$31.41	$101k	7.9%	Form 4
Aug 20, 2025	Phillip Benjamin (ben) Berry SVP, Chief Financial Officer	Bought	2,500	$29.71	$74k	2.2%	Form 4
Aug 13, 2025	Daniel A Pryor EVP, Strategy & Business Dev.	Bought	10,000	$28.90	$289k	6.5%	Form 4

Sep 4
Oliver Engert
Chief Administrative Officer · bought 2,660 at $18.80
$50k
4.3% of stake
Sep 4
Damien McDonald
Chief Executive Officer · bought 13,035 at $19.15
$250k
5.6% of stake
Sep 2 – 3
Oliver Engert
Chief Administrative Officer · bought 7,598 at avg $19.74
$150k
14% of stake
Jun 15
Oliver Engert
Chief Administrative Officer · bought 1,000 at $20.92
$21k
1.9% of stake
Jun 10
Oliver Engert
Chief Administrative Officer · bought 1,000 at $23.00
$23k
2.0% of stake
Jun 1
Oliver Engert
Chief Administrative Officer · bought 1,000 at $22.22
$22k
2.1% of stake
Mar 13
Oliver Engert
Chief Administrative Officer · bought 1,000 at $23.74
$24k
2.1% of stake
Mar 10
Oliver Engert
Chief Administrative Officer · bought 1,000 at $23.93
$24k
2.1% of stake
Mar 6 – 9
Oliver Engert
Chief Administrative Officer · bought 1,750 at avg $23.83
$42k
3.9% of stake
Mar 3 – 4
Oliver Engert
Chief Administrative Officer · bought 1,250 at avg $24.84
$31k
2.9% of stake
Feb 27
Oliver Engert
Chief Administrative Officer · bought 1,000 at $25.50
$26k
2.3% of stake
Dec 9, 2025No plan
Daniel A Pryor
Other · sold 1,665 at avg $27.21
$45k
1.0% of stake
Nov 25, 2025
John Kleckner
Principal Accounting Officer · bought 2,468 at $30.32
$75k
25% of stake
Sep 11, 2025
Damien McDonald
Chief Executive Officer · bought 6,457 at $30.97
$200k
6.7% of stake
Aug 22, 2025
Bradley J Tandy
SVP and Chief Legal Officer · bought 3,200 at $31.41
$101k
7.9% of stake
Aug 20, 2025
Phillip Benjamin (ben) Berry
SVP, Chief Financial Officer · bought 2,500 at $29.71
$74k
2.2% of stake
Aug 13, 2025
Daniel A Pryor
EVP, Strategy & Business Dev. · bought 10,000 at $28.90
$289k
6.5% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ENOV, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Orthopedic, Prosthetic & Surgical Appliances & Supplies

MSAMsa Safety Inc.

AVNSAvanos Medical Inc.

CDRECadre Holdings Inc.

ALGNAlign Technology, Inc.

INGNInogen Inc.

ESTAEstablishment Labs Holdings Inc.

STESTERIS plc

EWEdwards Lifesciences Corporation

Spot a number that looks wrong? Check it in ENOV's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ENOV

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.